Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...
Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic ...
Robert M. Rifkin, MD, FACP, discusses how the MagnetisMM-3 update at the 66th American Society of Hematology Annual Meeting and Exposition sheds light on elranatamab’s role in relapsed/refractory ...
Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.
The top U.S. health official is calling for all alcoholic beverages to carry a warning label about cancer risk.
Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.
The Healthy on MSN6d
11 Common Illnesses That Have Been Linked to Alzheimer’sAlthough we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.
Highlights in chronic myeloid leukemia from ASH 2024 include data on efficacy of asciminib over TKIs, benefit from the third-generation TKI olverembatinib, and importance of molecular monitoring.
The randomized phase III AALL1731 trial presented at the American Society of Hematology annual meeting showed that adding the ...
Symptom improvement with novel therapies and better patient-reported outcomes, as well as breakthrough hemolysis control, are among the paroxysmal nocturnal hemoglobinuria highlights from ASH 2024.
NEW YORK (CNN) — Following a brief outage that grounded all American Airlines flights during one of the busiest travel periods of the year, the company says it has resumed service Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback